First Header Logo Second Header Logo

Search Results (5)

More Search Options
MatchTypeWhy
An interleukin 13 receptor a 2-specific peptide homes to human Glioblastoma multiforme xenografts.Academic Article Why?
Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme.Academic Article Why?
Protein- and DNA-based active immunotherapy targeting interleukin-13 receptor alpha2.Academic Article Why?
Molecular targeting with recombinant cytotoxins of interleukin-13 receptor alpha2-expressing glioma.Academic Article Why?
Interleukin-13 Receptor alpha1 SubunitConcept Why?
Interleukin-13 Receptor alpha2 SubunitConcept Why?
Receptors, Interleukin-13Concept Why?
Debinski, WaldemarPerson Why?
Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy.Academic Article Why?
IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13.Academic Article Why?
Interleukin 13 mutants of enhanced avidity toward the glioma-associated receptor, IL13Ralpha2.Academic Article Why?
A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Ra2 tumor-restricted biomarker.Academic Article Why?
IL13RA2 targeted alpha particle therapy against glioblastomas.Academic Article Why?
New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors.Academic Article Why?
Reoxygenation of hypoxic glioblastoma multiforme cells potentiates the killing effect of an interleukin-13-based cytotoxin.Academic Article Why?
Per Page    Page  of 1
Next
Prev
Search Criteria
  • Receptors Interleukin 13
Filter by Type
_
Click "Why?" to see why an item matched the search.